Lifeward Ltd (LFWD) Stock Price, Quote & News

Company Profile

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gra...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 4 959 0123

Website: golifeward.com

Address:

3 Hatnufa Street, Floor 6, Yokneam Illit, Israel

SPYmyQQQ Sep. 9 at 12:01 AM

🌙 EOD Recap ✅ $LFWD 🗓️ Sep 8, 2025 (8pm ET) 💵 Our Entry: $0.5300 🎯 Target: $0.6249 (+17.91%)

0 · Reply

prismmarketview Sep. 8 at 3:31 PM

(NASDAQ: $LFWD) Lifeward lands CE mark approval for its ReWalk 7 exoskeleton—clearing the way for commercial sales across Europe. The 7th-gen model adds cloud connectivity, push-button control, and improved stair/curb navigation to enhance mobility. https://prismmarketview.com/lifeward-gains-ce-mark-for-rewalk-7-exoskeleton-strengthening-european-market-position/

0 · Reply

REALOSCAR Sep. 8 at 12:36 PM

$LFWD lets go over $1 today

1 · Reply

EvE12 Sep. 8 at 12:34 PM

$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-achieves-ce-mark-approval-rewalk-7-personal-exoskeleton

0 · Reply

SPYmyQQQ Sep. 8 at 10:03 AM

🚨 New Signal ✅ 💊 $LFWD 🗓️ Sep 8, 2025 💵 Entry: $0.5300 🎯 Suggested Target: $0.6249 (+17.91%) (Optional)

0 · Reply

Kjskms Sep. 7 at 5:36 AM

$LFWD (Shareholders' Coalition) We must reclaim the rights of shareholders that the company has neglected. We must prevent additional capital increases and reverse splits and reclaim shareholder rights like those of Open Technology (OPEN).

0 · Reply

Kjskms Sep. 7 at 2:19 AM

$LFWD Shareholders, unite! Rise up!

0 · Reply

Kjskms Sep. 7 at 2:16 AM

$LFWD The company could turn a profit just by reducing executive salaries.

0 · Reply

Kjskms Sep. 5 at 9:30 PM

$LFWD Executives, work for free

0 · Reply

themosad Sep. 5 at 2:50 PM

$LFWD spit stock ?

0 · Reply

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Aug 14, 2025, 10:26 PM EDT - 25 days ago

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 8:00 AM EDT - 25 days ago

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 8:00 AM EDT - 26 days ago

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 7, 2025, 5:30 PM EDT - 4 weeks ago

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 4, 2025, 8:30 AM EDT - 5 weeks ago

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Jul 7, 2025, 11:00 AM EDT - 2 months ago

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jun 26, 2025, 4:15 PM EDT - 2 months ago

Lifeward Announces Closing of $2.6 Million Public Offering

Jun 25, 2025, 9:10 AM EDT - 2 months ago

Lifeward Announces Pricing of $2.6 Million Public Oﬀering

Jun 24, 2025, 4:05 PM EDT - 2 months ago

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

May 19, 2025, 8:30 AM EDT - 4 months ago

Lifeward Names Mark Grant as New CEO

May 19, 2025, 6:00 AM EDT - 4 months ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 15, 2025, 9:53 AM EDT - 4 months ago

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

May 15, 2025, 8:00 AM EDT - 4 months ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 8, 2025, 8:30 AM EDT - 4 months ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 7, 2025, 4:30 PM EDT - 4 months ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

Apr 29, 2025, 8:30 AM EDT - 4 months ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 4 months ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 15, 2025, 8:15 AM EDT - 5 months ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Mar 13, 2025, 9:15 AM EDT - 6 months ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 7, 2025, 11:32 AM EST - 6 months ago

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Mar 7, 2025, 8:00 AM EST - 6 months ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 6, 2025, 8:00 AM EST - 6 months ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 5, 2025, 8:00 AM EST - 6 months ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Feb 28, 2025, 8:00 AM EST - 6 months ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 19, 2025, 9:10 AM EST - 7 months ago

Lifeward Announces CEO Transition

Jan 13, 2025, 8:30 AM EST - 8 months ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 7:45 AM EST - 8 months ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 8, 2025, 4:15 PM EST - 8 months ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 8 months ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 27, 2024, 5:49 PM EST - 9 months ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Nov 19, 2024, 8:30 AM EST - 10 months ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 12, 2024, 11:30 AM EST - 10 months ago

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:00 AM EST - 10 months ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:38 PM EST - 10 months ago

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Oct 24, 2024, 4:30 PM EDT - 11 months ago

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Sep 24, 2024, 5:00 PM EDT - 1 year ago

Lifeward Launches Direct Sales of AlterG Product Line in Germany

Sep 12, 2024, 8:30 AM EDT - 1 year ago

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Sep 10, 2024, 8:30 AM EDT - 1 year ago

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 15, 2024, 1:07 PM EDT - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:15 PM EDT - 1 year ago

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Jul 2, 2024, 4:30 PM EDT - 1 year ago

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Jun 4, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

May 15, 2024, 1:06 PM EDT - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

May 15, 2024, 8:00 AM EDT - 1 year ago

Lifeward Reports First Quarter 2024 Financial Results

May 7, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Report First Quarter Financial Results on May 15, 2024

Apr 19, 2024, 8:30 AM EDT - 1 year ago

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

SPYmyQQQ Sep. 9 at 12:01 AM

🌙 EOD Recap ✅ $LFWD 🗓️ Sep 8, 2025 (8pm ET) 💵 Our Entry: $0.5300 🎯 Target: $0.6249 (+17.91%)

0 · Reply

prismmarketview Sep. 8 at 3:31 PM

0 · Reply

REALOSCAR Sep. 8 at 12:36 PM

$LFWD lets go over $1 today

1 · Reply

EvE12 Sep. 8 at 12:34 PM

$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-achieves-ce-mark-approval-rewalk-7-personal-exoskeleton

0 · Reply

SPYmyQQQ Sep. 8 at 10:03 AM

🚨 New Signal ✅ 💊 $LFWD 🗓️ Sep 8, 2025 💵 Entry: $0.5300 🎯 Suggested Target: $0.6249 (+17.91%) (Optional)

0 · Reply

Kjskms Sep. 7 at 5:36 AM

0 · Reply

Kjskms Sep. 7 at 2:19 AM

$LFWD Shareholders, unite! Rise up!

0 · Reply

Kjskms Sep. 7 at 2:16 AM

$LFWD The company could turn a profit just by reducing executive salaries.

0 · Reply

Kjskms Sep. 5 at 9:30 PM

$LFWD Executives, work for free

0 · Reply

themosad Sep. 5 at 2:50 PM

$LFWD spit stock ?

0 · Reply

Kjskms Sep. 5 at 11:07 AM

$LFWD beggarly stocks

0 · Reply

Kjskms Sep. 5 at 7:18 AM

$LFWD The executives here are paid too high.

0 · Reply

themosad Sep. 4 at 4:57 PM

$LFWD all ok ? Its no fear

0 · Reply

REALOSCAR Sep. 4 at 3:25 PM

$NEON lets keep going guys $OPEN $LFWD

0 · Reply

Diverstj981 Sep. 4 at 1:52 PM

$LFWD

0 · Reply

REALOSCAR Sep. 4 at 1:35 PM

$LFWD

0 · Reply

Leemarvin70 Sep. 3 at 8:04 PM

$LFWD justo cuando pensaba que está 💩 no podía caer aún más bajo

0 · Reply

Kjskms Sep. 3 at 6:17 PM

$LFWD Here's a final tip: If management has a vision for the company's stock, the CEO should start buying the company's stock.

0 · Reply

REALOSCAR Sep. 3 at 4:15 PM

$LFWD we just need volume

0 · Reply

Big_Baggies Sep. 3 at 2:46 PM

$LFWD when does tax loss selling season begin @kurtb1969?

2 · Reply

Kjskms Sep. 3 at 2:26 PM

$LFWD Even if I tell you that, you still don't understand?

0 · Reply

transamlover Sep. 2 at 10:25 PM

$LFWD ...bought about 1900 shares today, see what happens

0 · Reply

Market Cap	8.32M
Revenue (ttm)	25.66M
Net Income (ttm)	-28.94M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-112.78%
Debt to Equity Ratio	0.00

Volume	324,800
Avg Vol	482,788
Day's Range	N/A - N/A
Shares Out	15.71M
Stochastic %K	14%
Beta	0.16
Analysts	Strong Sell
Price Target	$8.00